![Ruby Casareno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruby Casareno occupe le poste de vice-président des opérations techniques chez Allakos, Inc. Mme Casareno a obtenu un diplôme de premier cycle à l'université des Philippines et un doctorat à l'université d'État de l'Ohio.
| Sociétés | Poste | Fin |
|---|---|---|
| ALLAKOS INC. | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Philippines
 University of the Philippines Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
